-
EP3307271
European procedure
Extract from the Register of European Patents
EP About this file: EP3307271
| EP3307271 - METHODS OF USING PYRUVATE KINASE ACTIVATORS [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 11.08.2023 Database last updated on 24.08.2024 | |
| Former | Grant of patent is intended Status updated on 29.03.2023 | ||
| Former | Examination is in progress Status updated on 16.03.2020 | ||
| Former | Request for examination was made Status updated on 22.03.2018 | ||
| Former | The international publication has been made Status updated on 16.12.2016 | Most recent event Tooltip | 24.06.2024 | New entry: Communication of a notice of opposition and request to file observations + time limit | Applicant(s) | For all designated states Agios Pharmaceuticals, Inc. 88 Sidney Street Cambridge, MA 02139 / US | [2018/16] | Inventor(s) | 01 /
AGRESTA, Samuel, V. 24 Coolidge Road Lexington, MA 02420 / US | 02 /
CHEN, Yue 2001 Falls Boulevard Apt. 321 Quincy, MA 02169 / US | 03 /
COHEN, Marvin, Barry 110 North Lincoln Avenue Newtown, PA 18940 / US | 04 /
DANG, Leonard Luan, C. 30 Union Park Street 201 Boston, MA 02118 / US | 05 /
KUNG, Charles 39 Rockmont Road Arlington, MA 02474 / US | 06 /
MERICA, Elizabeth, A. 227B Lamartine Street Boston, MA 02130 / US | 07 /
SILVER, Bruce, Alan 12132 Palisades Drive Dunkirk, MD 20754 / US | 08 /
YANG, Hua 48 Conant Street Acton, MA 01720 / US | [2018/16] | Representative(s) | Maiwald GmbH Elisenhof Elisenstraße 3 80335 München / DE | [2023/37] |
| Former [2018/16] | Bösl, Raphael Konrad Isenbruck Bösl Hörschler LLP Patentanwälte Prinzregentenstraße 68 81675 München / DE | Application number, filing date | 16808374.9 | 10.06.2016 | [2018/16] | WO2016US36893 | Priority number, date | US201562174216P | 11.06.2015 Original published format: US 201562174216 P | [2018/16] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016201227 | Date: | 15.12.2016 | Language: | EN | [2016/50] | Type: | A1 Application with search report | No.: | EP3307271 | Date: | 18.04.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 15.12.2016 takes the place of the publication of the European patent application. | [2018/16] | Type: | B1 Patent specification | No.: | EP3307271 | Date: | 13.09.2023 | Language: | EN | [2023/37] | Search report(s) | International search report - published on: | US | 15.12.2016 | (Supplementary) European search report - dispatched on: | EP | 03.01.2019 | Classification | IPC: | A61K31/4709, A61K31/496, C07D215/36, A61P7/06 | [2019/03] | CPC: |
A61K31/496 (EP,US);
A61P7/06 (EP,US)
|
| Former IPC [2018/16] | A61K31/4709, A61K31/496, C07D215/36 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/16] | Extension states | BA | 10.01.2018 | ME | 10.01.2018 | Validation states | MA | 10.01.2018 | MD | 10.01.2018 | Title | German: | VERFAHREN ZUR VERWENDUNG VON PYRUVATKINASEAKTIVATOREN | [2018/16] | English: | METHODS OF USING PYRUVATE KINASE ACTIVATORS | [2018/16] | French: | PROCÉDÉS D'UTILISATION D'ACTIVATEURS DE LA PYRUVATE KINASE | [2018/16] | Entry into regional phase | 10.01.2018 | National basic fee paid | 10.01.2018 | Search fee paid | 10.01.2018 | Designation fee(s) paid | 10.01.2018 | Examination fee paid | Examination procedure | 10.01.2018 | Examination requested [2018/16] | 10.01.2018 | Date on which the examining division has become responsible | 01.08.2019 | Amendment by applicant (claims and/or description) | 19.03.2020 | Despatch of a communication from the examining division (Time limit: M04) | 27.07.2020 | Reply to a communication from the examining division | 18.02.2021 | Despatch of a communication from the examining division (Time limit: M06) | 16.08.2021 | Reply to a communication from the examining division | 30.03.2023 | Communication of intention to grant the patent | 02.08.2023 | Fee for grant paid | 02.08.2023 | Fee for publishing/printing paid | 02.08.2023 | Receipt of the translation of the claim(s) | Divisional application(s) | EP23196616.9 / EP4344703 | Opposition(s) | Opponent(s) | 01
11.06.2024
13.06.2024
ADMISSIBLE BOTTI & FERRARI S.p.A. Via Cappellini, 11 20124 Milano / IT Opponent's representative Botti & Ferrari S.p.A. Via Cappellini, 11 20124 Milano / IT | 02
13.06.2024
14.06.2024
ADMISSIBLE Sandoz AG Lichtstrasse 35 4056 Basel / CH Opponent's representative Ter Meer Steinmeister & Partner Patentanwälte mbB Nymphenburger Straße 4 80335 München / DE | [2024/29] | 25.06.2024 | Invitation to proprietor to file observations on the notice of opposition | Fees paid | Renewal fee | 27.06.2018 | Renewal fee patent year 03 | 27.06.2019 | Renewal fee patent year 04 | 29.06.2020 | Renewal fee patent year 05 | 28.06.2021 | Renewal fee patent year 06 | 27.06.2022 | Renewal fee patent year 07 | 27.06.2023 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | deleted | [2024/30] |
| Former [2024/24] | SK | 13.09.2023 | Documents cited: | Search | [XY]WO2012151451 (AGIOS PHARMACEUTICALS INC [US], et al); | International search | [Y]US2014155408 (SU SHIN-SAN MICHAEL [US]); | [XY]US2014323467 (SALITURO FRANCESCO G [US], et al); | by applicant | WO2012151451 | US8785450 | Opposition | WO2012151451 |